The Oncology Based Molecular Diagnostics Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Oncology Based Molecular Diagnostics Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive...

According to a new report by Polaris Market Research, the global oncology-based molecular diagnostics market was valued at USD 3.66 billion in 2024 and is projected to reach USD 6.12 billion by 2034, expanding at a CAGR of 5.3% over the forecast period. Growth is underpinned by rising cancer incidence worldwide, expanding adoption of precision oncology testing, and accelerating...

Genomics is having a moment. As sequencing costs keep falling and clinical adoption keeps rising, next generation sequencing (NGS) has moved from a research-lab novelty to a cornerstone of modern diagnostics and drug development. Here's a look at where the market stands today, who's leading it, and what's driving its next phase of growth. Market Snapshot The global next generation sequencing...

Global Radiopharmaceutical Market Growing at 9.3% CAGR | Industry Forecast 2024–2032 According to Straits Research, the global Radiopharmaceutical Market was valued at USD XX Billion in 2023 and is projected to grow from USD XX Billion in 2024 to USD XX Billion by 2032, exhibiting a CAGR of 9.3% during...